Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dell'Osso, Bernardo
NCT04975724 / 2018-001622-26: Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder	Recruiting	4	150	Europe	Liposom Forte, Liposom, Citalopram, Placebo, Placebo of Liposom Forte	Fidia Farmaceutici s.p.a., Fidia Farmaceutici S.p.A.	Major Depressive Disorder	10/25	12/25
NCT04693351 / 2020-004653-69: Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder	Active, not recruiting	3	700	Europe, Canada, US, RoW	Troriluzole, Placebo	Biohaven Pharmaceuticals, Inc.	Obsessive-Compulsive Disorder	04/25	04/25